<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Juvenescence Limited 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=39780></link><description><![CDATA[Juvenescence Limited 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Thu, 30 Apr 2026 11:14:49 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2022/02/12_1026003021_20220202142334_9700165671.gif]]></url></image><language>ko-KR</language><item><title><![CDATA[JUVENESCENCE Appoints Dr Richard Marshall CBE as CEO]]></title><link>https://www.newswire.co.kr/newsRead.php?no=959864</link><description><![CDATA[RAMSEY, Isle of Man--(Business Wire/Korea Newswire)--Juvenescence has named Dr Richard Marshall CBE as its new CEO, effective 16 January 2023. Dr Marshall succeeds co-founder Dr Gregory Bailey, who will remain on the company’s board as Executive Chairman.  Dr Marshall brings over twenty years of business leadership to the company, with fifteen years at GSK culminating in his position as Vice Presi...]]></description><pubDate>Tue, 17 Jan 2023 10:15:00 +0900</pubDate></item><item><title><![CDATA[JUVENESCENCE, Richard Marshall 박사 CBE를 CEO로 임명]]></title><link>https://www.newswire.co.kr/newsRead.php?no=959865</link><description><![CDATA[램지, 맨섬--(Business Wire/뉴스와이어)--Juvenescence는 2023년 1월 16일 자로 Richard Marshall 박사 CBE를 새 CEO로 지명했다. Marshall 박사는 회사 이사회에서 계속 회장으로 활동하게 될 공동 설립자 Gregory Bailey 박사의 뒤를 잇는다.  Marshall 박사는 GSK에서 경력상 최고 직책으로는 15년간의 섬유증 및 폐 손상 발견 성과 유닛(Head of the Fibrosis &amp; Lung Injury Discovery Performance Unit, DP...]]></description><pubDate>Tue, 17 Jan 2023 10:15:00 +0900</pubDate></item><item><title><![CDATA[Juvenescence Ltd. Portfolio Company Hails Successful Limb Regeneration in Adult Frogs]]></title><link>https://www.newswire.co.kr/newsRead.php?no=938920</link><description><![CDATA[DOUGLAS, Isle of Man--(Business Wire/Korea Newswire)--Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration of limbs in Xenopus laevis (African clawed frog). This is the first demonstration of functional limb regeneration in a species that does not show spontaneous reg...]]></description><pubDate>Wed, 02 Feb 2022 15:00:00 +0900</pubDate></item><item><title><![CDATA[유벤에센스의 포트폴리오 기업, 개구리 성체의 팔다리 재생 입증]]></title><link>https://www.newswire.co.kr/newsRead.php?no=938921</link><description><![CDATA[더글라스, 맨 섬--(Business Wire/뉴스와이어)--유벤에센스(Juvenescence Ltd.)의 포트폴리오 기업 모르포수티컬즈(Morphoceuticals Inc.) 설립자들이 사이언스 어드밴스즈(Science Advances)에 장기 연구 결과를 게재했다.   연구 결과에 따르면 이들은 제노푸스 라에비스(Xenopus laevis, 아프리카발톱개구리)의 팔다리를 성공적으로 재생했다. 팔다리가 자발적으로 재생하지 않는 성체 종의 팔다리를 기능적으로 재생하...]]></description><pubDate>Wed, 02 Feb 2022 15:00:00 +0900</pubDate></item></channel></rss>